A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

Trial Profile

A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age

Suspended
Phase of Trial: Phase IV

Latest Information Update: 25 Sep 2017

At a glance

  • Drugs MEDI 3250 (Primary) ; Influenza virus vaccine
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Acronyms ICICLE
  • Sponsors MedImmune
  • Most Recent Events

    • 10 Apr 2017 Results (n=1696) published in the Vaccine.
    • 06 Sep 2016 Results of post-hoc analysis investigating the association between the lack of LAIV effectiveness against H1N1pdm09 strains and vaccine lot handling conditions during distribution published in the Vaccine.
    • 06 Sep 2016 Planned End Date changed from 1 Jun 2017 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top